Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 1 Interventional

CNP-201 in Subjects With Peanut Allergy

ClinicalTrials.gov ID: NCT05250856

Public ClinicalTrials.gov record NCT05250856. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b/2a Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of CNP-201 in Subjects Ages 16-55 With Peanut Allergy

Study identification

NCT ID
NCT05250856
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 1
Lead sponsor
COUR Pharmaceutical Development Company, Inc.
Industry
Enrollment
15 participants

Conditions and interventions

Conditions

Interventions

  • CNP-201 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
16 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 13, 2022
Primary completion
Dec 11, 2023
Completion
Dec 11, 2023
Last update posted
Dec 19, 2023

2022 – 2023

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
AllerVie Clinical Research Birmingham Alabama 35209
Long Beach Clinical Trials, LLC Long Beach California 90806
Southern California Research Mission Viejo California 92691
Allergy & Asthma Medicaal Group and Research Center San Diego California 60062
Rush University Medical Center Chicago Illinois 60612
Sneeze, Wheeze and Itch Associates, LLC Normal Illinois 61761
Meridian Clinical Research. LLC Overland Park Kansas 66210
Institute for Asthma & Allergy Chevy Chase Maryland 20815
Aventiv Research, Inc Columbus Ohio 43213
Vital Prospects Clinica Research Institute Tulsa Oklahoma 74136
National Allergy and Asthma Research, LLC North Charleston South Carolina 29420
Allergy Partners of North Texas Research Dallas Texas 75230
Pharmaceutical Research & Consulting, Inc Dallas Texas 75231
Western Sky Medical Research El Paso Texas 79903
Tranquil Clinical and Research Consulting Services Houston Texas 77598
Clinical Research Partners Richmond Virginia 23226
Seattle Allergy & Asthma Research Institute Seattle Washington 98115

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05250856, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 19, 2023 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05250856 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →